Dr. Peter S. Fail, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
Who else practices at this address →
Terrebonne Parish is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 1,137
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
LA license 11924R -
Cardiovascular Disease Physician
LA license 11924R -
Interventional Cardiology Physician
LA license 11924R
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- Ochsner Lafayette General Medical Center Lafayette, LA
- Thibodaux Regional Medical Center Thibodaux, LA
- Terrebonne General Medical Center - PArish Houma, LA
- Ochsner St Mary Morgan City, LA
- Lady of the Sea General Hospital Cut Off, LA
Medical groups
- Cardiovascular Institute of the South, LLC (146 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,137
- Services billed
- 48,655
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19,530 | 174 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,024 | 664 |
| Blood test, lipids (cholesterol and triglycerides) | 707 | 475 |
| Liver enzyme (sgot), level | 584 | 381 |
| Liver enzyme (sgpt), level | 583 | 380 |
| Phosphatase (enzyme) level, alkaline | 581 | 379 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 398 | 49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 361 | 275 |
| Blood test, basic group of blood chemicals (calcium, total) | 337 | 227 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 288 | 257 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Atorvastatin Calcium Other prescribers in Houma, LA | 1,295 |
| Rosuvastatin Calcium Other prescribers in Houma, LA | 1,278 |
| Metoprolol Succinate Other prescribers in Houma, LA | 1,274 |
| Ezetimibe Other prescribers in Houma, LA | 907 |
| Jardiance (empagliflozin) Other prescribers in Houma, LA | 904 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Houma, LA | 716 |
| Amlodipine Besylate Other prescribers in Houma, LA | 700 |
| Valsartan Other prescribers in Houma, LA | 689 |
| Entresto (sacubitril/valsartan) Other prescribers in Houma, LA | 674 |
| Spironolactone Other prescribers in Houma, LA | 659 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 100 payments worth $10,397 in total to this clinician.
| Medtronic, Inc. | $4,087 |
|---|---|
| Edwards Lifesciences Corporation | $3,366 |
| Abbott Laboratories | $1,541 |
| Ancora Heart, Inc. | $435 |
| E.r. Squibb & Sons, L.l.c. | $186 |
| Abiomed | $179 |
| Angiodynamics, Inc. | $166 |
| Terumo Medical Corporation | $120 |
| Food and Beverage | $4,227 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $3,050 |
| Travel and Lodging | $2,244 |
| Consulting Fee | $875 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Oct 23, 2025 | Consulting Fee AMPLATZER AMULET · Structural Heart | $875 |
| Edwards Lifesciences Corporation Sep 3, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $724 |
| Medtronic, Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $500 |
| Edwards Lifesciences Corporation Oct 8, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $496 |
| Edwards Lifesciences Corporation May 23, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $405 |
| Medtronic, Inc. Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $375 |
| Edwards Lifesciences Corporation Jun 21, 2025 | Travel and Lodging EVOQUE · Transcatheter Valve Repair · travel to Atlanta, GA · in-kind | $343 |
| Medtronic, Inc. Dec 12, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $300 |
| Medtronic, Inc. Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
All 26 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Dec 12, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $300 |
| Medtronic, Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Oct 29, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Oct 25, 2025 | Travel and Lodging COREVALVE EVOLUT R · Transcatheter Valve Systems · travel to San Francisco, CA · in-kind | $9.15 |
| Abbott Laboratories Oct 23, 2025 | Consulting Fee AMPLATZER AMULET · Structural Heart | $875 |
| Edwards Lifesciences Corporation Oct 8, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $496 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $23.01 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $19.70 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $7.13 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5.45 |
| Edwards Lifesciences Corporation Oct 6, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $5.16 |
| Medtronic, Inc. Sep 11, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $125 |
| Edwards Lifesciences Corporation Sep 3, 2025 | Travel and Lodging travel to Irvine, CA · in-kind | $724 |
| Medtronic, Inc. Jul 14, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $125 |
| Edwards Lifesciences Corporation Jun 26, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $169 |
| Edwards Lifesciences Corporation Jun 21, 2025 | Travel and Lodging EVOQUE · Transcatheter Valve Repair · travel to Atlanta, GA · in-kind | $343 |
| Medtronic, Inc. Jun 16, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Edwards Lifesciences Corporation May 23, 2025 | Travel and Lodging travel to Atlanta, GA · in-kind | $405 |
| Medtronic, Inc. Apr 4, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Feb 20, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $250 |
| Medtronic, Inc. Feb 7, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $125 |
| Medtronic, Inc. Feb 4, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $500 |
| Medtronic, Inc. Jan 21, 2025 | Compensation for services other than consulting (speaking, faculty) COREVALVE EVOLUT R · Transcatheter Valve Systems | $375 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 10 industry-funded studies in 2025, from 6 companies. The companies reported $61,067 in research payments for these studies, mostly to the institutions running them.
- JOURNEY (Trial JCM-002)
Edwards Lifesciences Corporation - A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Dis…
Novartis Pharmaceuticals Corporation - A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction
Merck Sharp & Dohme LLC - NCT03904147--TRILUMINATE Pivotal Trial
Abbott Laboratories - EXPAND II
Medtronic, Inc. - CoreValve SURTAVI
Medtronic, Inc. - NCT04226547--Amplatzer Amulet LAAO vs. NOAC
Abbott Laboratories - TAVR Low Risk
Medtronic, Inc. - A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Novartis Pharmaceuticals Corporation - LOWER: Lomitapide Observational Worldwide Evaluation Registry
Chiesi USA, Inc. · Completed · NCT02135705
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.